AGLE Annual Non Current Assets
$8.89 M
-$2.15 M-19.47%
31 December 2022
Summary:
As of February 5, 2025, AGLE annual long term assets is $8.89 million, with the most recent change of -$2.15 million (-19.47%) on December 31, 2022. During the last 3 years, it has risen by +$208.00 thousand (+2.40%).AGLE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGLE Quarterly Non Current Assets
$1.32 M
-$2.33 M-63.88%
30 September 2023
Summary:
As of February 5, 2025, AGLE quarterly long term assets is $1.32 million, with the most recent change of -$2.33 million (-63.88%) on September 30, 2023. Over the past year, it has dropped by -$8.03 million (-85.92%).AGLE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGLE Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.5% | -85.9% |
| 3 y3 years | +2.4% | -88.3% |
| 5 y5 years | +718.2% | +47.0% |
AGLE Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -24.9% | -89.6% |
Aeglea BioTherapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $1.32 M(-63.9%) |
| June 2023 | - | $3.64 M(-54.9%) |
| Mar 2023 | - | $8.08 M(-9.1%) |
| Dec 2022 | $62.26 M(-37.0%) | $8.89 M(-4.9%) |
| Sept 2022 | - | $9.35 M(-7.1%) |
| June 2022 | - | $10.06 M(-4.9%) |
| Mar 2022 | - | $10.57 M(-4.2%) |
| Dec 2021 | $98.89 M(-34.0%) | $11.04 M(-4.4%) |
| Sept 2021 | - | $11.55 M(-8.5%) |
| June 2021 | - | $12.61 M(+3.4%) |
| Mar 2021 | - | $12.20 M(+3.2%) |
| Dec 2020 | $149.79 M(+101.0%) | $11.83 M(+5.3%) |
| Sept 2020 | - | $11.23 M(+1.7%) |
| June 2020 | - | $11.04 M(+5.0%) |
| Mar 2020 | - | $10.52 M(+21.2%) |
| Dec 2019 | $74.50 M | $8.68 M(+16.2%) |
| Sept 2019 | - | $7.47 M(-1.2%) |
| June 2019 | - | $7.56 M(+344.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $1.70 M(+59.3%) |
| Dec 2018 | $76.67 M(+39.4%) | $1.07 M(+19.3%) |
| Sept 2018 | - | $895.00 K(+8.5%) |
| June 2018 | - | $825.00 K(-12.5%) |
| Mar 2018 | - | $943.00 K(-13.2%) |
| Dec 2017 | $54.99 M(-17.2%) | $1.09 M(+10.5%) |
| Sept 2017 | - | $983.00 K(+4.5%) |
| June 2017 | - | $941.00 K(-2.2%) |
| Mar 2017 | - | $962.00 K(+50.5%) |
| Dec 2016 | $66.42 M(+73.5%) | $639.00 K(+67.3%) |
| Sept 2016 | - | $382.00 K(-3.3%) |
| June 2016 | - | $395.00 K(+16.5%) |
| Mar 2016 | - | $339.00 K(-7.9%) |
| Dec 2015 | $38.29 M(+1302.4%) | $368.00 K(-1.9%) |
| Sept 2015 | - | $375.00 K(+40.4%) |
| June 2015 | - | $267.00 K(+4.7%) |
| Mar 2015 | - | $255.00 K(+27.5%) |
| Dec 2014 | $2.73 M(-40.6%) | $200.00 K |
| Dec 2013 | $4.60 M | - |
FAQ
- What is Aeglea BioTherapeutics annual long term assets?
- What is the all time high annual non current assets for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics annual non current assets year-on-year change?
- What is Aeglea BioTherapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics quarterly non current assets year-on-year change?
What is Aeglea BioTherapeutics annual long term assets?
The current annual non current assets of AGLE is $8.89 M
What is the all time high annual non current assets for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high annual long term assets is $11.83 M
What is Aeglea BioTherapeutics annual non current assets year-on-year change?
Over the past year, AGLE annual long term assets has changed by -$2.15 M (-19.47%)
What is Aeglea BioTherapeutics quarterly long term assets?
The current quarterly non current assets of AGLE is $1.32 M
What is the all time high quarterly non current assets for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high quarterly long term assets is $12.61 M
What is Aeglea BioTherapeutics quarterly non current assets year-on-year change?
Over the past year, AGLE quarterly long term assets has changed by -$8.03 M (-85.92%)